癌症研究
癌症
医学
肝细胞癌
肿瘤科
内科学
癌
作者
Can Chen,Yi Zong,Jiaojiao Tang,Ruisheng Ke,Lizhi Lv,Mengchao Wu,Jun‐Hua Lu
出处
期刊:Personalized Medicine
[Future Medicine]
日期:2021-04-01
卷期号:18 (4): 375-388
被引量:3
标识
DOI:10.2217/pme-2020-0012
摘要
Background: The aim of this study was to investigate the role of miR-369-3p in hepatocellular carcinoma (HCC). Materials & methods: The expression levels of miR-369-3p were detected using the quantitative real-time reverse transcription-PCR analysis. The cell counting kit-8 and transwell assays were used to explore the effects of miR-369-3p on cell proliferation, migration and invasion of HCC cells. Results: The miR-369-3p expression was downregulated in HCC tissues and cell lines, in comparison to the normal controls, respectively. In vitro, overexpression of miR-369-3p in Hep 3B and Huh7 cells inhibited cell proliferation, migration and invasion. SOX4 was a direct target of miR-369-3p. Conclusion: Our results suggested that miR-369-3p may be a tumor suppressor in HCC by targeting SOX4.
科研通智能强力驱动
Strongly Powered by AbleSci AI